| pubmed-article:15201806 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15201806 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:15201806 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
| pubmed-article:15201806 | lifeskim:mentions | umls-concept:C0751973 | lld:lifeskim |
| pubmed-article:15201806 | lifeskim:mentions | umls-concept:C0695347 | lld:lifeskim |
| pubmed-article:15201806 | lifeskim:mentions | umls-concept:C1516193 | lld:lifeskim |
| pubmed-article:15201806 | lifeskim:mentions | umls-concept:C0205473 | lld:lifeskim |
| pubmed-article:15201806 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15201806 | pubmed:dateCreated | 2004-6-17 | lld:pubmed |
| pubmed-article:15201806 | pubmed:abstractText | Various strategies have recently emerged to improve the diagnostic prediction of prostate cancer (CaP). One such strategy includes the mass profiling of serum protein fractions selectively adsorbed onto chemically modified probes. In the current study we further validated this approach, while offering a more versatile, less expensive and yet equally predictive alternative to existing technologies. | lld:pubmed |
| pubmed-article:15201806 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15201806 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15201806 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15201806 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15201806 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15201806 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15201806 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15201806 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:15201806 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:15201806 | pubmed:author | pubmed-author:LauK MKM | lld:pubmed |
| pubmed-article:15201806 | pubmed:author | pubmed-author:KES JSJ | lld:pubmed |
| pubmed-article:15201806 | pubmed:author | pubmed-author:MaoZ YZY | lld:pubmed |
| pubmed-article:15201806 | pubmed:author | pubmed-author:PaisV MVM | lld:pubmed |
| pubmed-article:15201806 | pubmed:author | pubmed-author:BluteR DRD | lld:pubmed |
| pubmed-article:15201806 | pubmed:author | pubmed-author:SteadmanBB | lld:pubmed |
| pubmed-article:15201806 | pubmed:author | pubmed-author:TaplinM EME | lld:pubmed |
| pubmed-article:15201806 | pubmed:author | pubmed-author:MobleyJ AJA | lld:pubmed |
| pubmed-article:15201806 | pubmed:author | pubmed-author:L'EsperanceJ... | lld:pubmed |
| pubmed-article:15201806 | pubmed:author | pubmed-author:FusterL M... | lld:pubmed |
| pubmed-article:15201806 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15201806 | pubmed:volume | 172 | lld:pubmed |
| pubmed-article:15201806 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15201806 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15201806 | pubmed:pagination | 331-7 | lld:pubmed |
| pubmed-article:15201806 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:meshHeading | pubmed-meshheading:15201806... | lld:pubmed |
| pubmed-article:15201806 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15201806 | pubmed:articleTitle | Monitoring the serological proteome: the latest modality in prostate cancer detection. | lld:pubmed |
| pubmed-article:15201806 | pubmed:affiliation | Division of Urology, Department of Surgery, University of Massachusetts Medical School, Worcester, Massachusetts 01605-2324, USA. | lld:pubmed |
| pubmed-article:15201806 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15201806 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15201806 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15201806 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15201806 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15201806 | lld:pubmed |
